FibroGen, Inc. (FGEN)
8.60
-0.10
(-1.15%)
USD |
NASDAQ |
Dec 31, 15:24
FibroGen Market Cap: 34.76M for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Assertio Holdings, Inc. | 58.14M |
| Perspective Therapeutics, Inc. | 202.57M |
| Skye Bioscience, Inc. | 23.41M |
| Theravance Biopharma, Inc. | 956.19M |
| Myomo, Inc. | 35.75M |
Market Cap Related Metrics
| PE Ratio | 0.2187 |
| PS Ratio | 29.29 |
| Price | 8.60 |
| Earnings Yield | 457.4% |
| Normalized PE Ratio | 0.2112 |